Targeting Heparan Sulfate 3-O-Sulfation Enhances Acetylcholine Receptor Clustering and Stabilizes Neuromuscular Junctions in Duchenne Muscular Dystrophy
Year: 2026
Type: preprint
Abstract: Duchenne muscular dystrophy (DMD) is a severe neuromuscular disease caused by dystrophin deficiency, leading to progressive muscle degeneration and neuromuscular junction (NMJ) instability. Using rat models of DMD, we identified a dysregulation in heparan sulfate (HS) biosynthesis at the NMJ, characterized by reduced expression of Hs6st2 and Hs3st5 genes that encode sulfotransferases required for the production of rare 3-O-sulfated heparan sulfate (3S-HS) forms. These genes act synergistically to enhance agrin signaling: their co-expression in myotubes potentiates acetylcholine receptor clustering, and HSPG mimics bearing tetrasulfated 3-O-sulfated motifs reproduce this effect and promote Agrin-LRP4 interaction. In DMD rats, muscle co-transduction of Hs6st2 and Hs3st5 prevents NMJ fragmentation and improves muscle strength. These findings identify 3S-HSs as novel regulators of NMJ stability and support HS modulation as a complementary therapeutic strategy in DMD.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7236821771
